Hereditary Cancer (CGx)
Testing

Genetics Institute of America currently offers analysis of 52 of the most clinically relevant genomic mutations associated with cancer. CGx testing provides patients with the information, education, and most importantly, opportunity to make life-altering decisions.
We firmly believe that genetic testing benefits health care providers better estimate their patient’s risk of developing cancer. With this in mind, patients and providers will be influenced to perform preventative actions such as:
  • Increased Self-examinations i.e clinical and self breast examinations
  • Increased thyroid examinations
  • Increased colonoscopy frequency
  • Risk-reducing prophylactic surgery and/or chemo prevention
  • Early and increased prostate cancer screenings
  • Consideration of MRI-based screening/technologies

What We Offer

Experienced Personnel

Your patient's health is your most important asset. You should entrust it only to the best professionals.

Timely Analysis & Reports

Due to our research findings and technology, we are able to provide timely reports of genetic and specialty testing.

Quality and Safety

All scientists and personnel at Genetics Institute of America have been trained thoroughly to assist in any situation.

Immediate Service

Our panels are designed for steady progress, with every phase promptly implemented.

Practice Enrollment

561-455-2162

Speak to one of our representatives today to learn more about enrolling your practice.

Get News & Updates

Sign up for important updates and additional information from our Care Coordinators.





Now Offering the GIAnomics Family of Genomics Tests

We offer extensive products and services to patients, medical professionals, and businesses.